Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of human MDS/AML cell line OCI-M2 treated with 5-azacytidine and sulforaphane


ABSTRACT: The RNA sequencing experiment is part of the study: “Modulating Redox Balance Restores Azacytidine Efficacy in Hypomethylating Agent Resistant Disease.” In the study we generated myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) OCI-M2 cell line that is resistant to hypomethylating therapy by 5-azacytidine (AZA). By modulation of the redox environment via modification of redox sensor KEAP1 using sulforaphane (SFN) in these cells we were able to restore sensitivity to AZA. We used RNA sequencing to define transcriptomic differences between AZA sensitive (AZA-S) and AZA resistant (AZA-R) cells and to characterize how the transcriptome is changing upon treatment of these cells with AZA, SFN and combination of both.

INSTRUMENT(S): NextSeq 500

ORGANISM(S): Homo sapiens

SUBMITTER: Juraj Kokavec 

PROVIDER: E-MTAB-10635 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2022-05-02 | E-MTAB-11172 | biostudies-arrayexpress
2024-10-13 | E-MTAB-14197 | biostudies-arrayexpress
2024-04-17 | PXD038663 | Pride
2014-06-13 | E-MTAB-280 | biostudies-arrayexpress
2024-04-17 | PXD046853 | Pride
2013-12-19 | E-GEOD-53448 | biostudies-arrayexpress
2015-04-29 | E-GEOD-57130 | biostudies-arrayexpress
2012-04-27 | E-GEOD-37630 | biostudies-arrayexpress
2016-02-10 | E-GEOD-77750 | biostudies-arrayexpress
2013-09-17 | E-GEOD-41586 | biostudies-arrayexpress